India Kidney Function Test Market By Test Type, By Component, By End User, By Region, Competition, Forecast & Opportunities, 2020-2030F

India Kidney Function Test Market was valued at USD 46.35 million in 2024 and is expected to reach USD 70.94 million by 2030 with a CAGR of 7.35% during the forecast period. This can be ascribed to the increased awareness about kidney diseases, that how it is important to detect kidney diseases early and to raise awareness among the people regarding kidney diseases in India. There has been a significant increase in the prevalence of kidney diseases in India over the last few decades. This increase is mainly attributed to changes in lifestyle, including unhealthy diets, lack of physical activity, and an increase in the prevalence of diabetes and hypertension. Patients are more informed about the benefits of early detection of kidney diseases, as a result, there is a growing need for early detection and management of kidney disease, which has led to an increase in demand for kidney function tests. These advancements have improved the accuracy and reliability of the tests, leading to greater acceptance of the tests by patients and healthcare professionals. Indian government has taken so many initiatives to improve healthcare in the country, including measures to increase access to kidney function tests.

For instance, the National Health Mission in India provides free diagnostic tests, including kidney function tests, to eligible individuals, which has helped to increase access to these tests. As the growing Indian economy has led to greater investments in healthcare infrastructure, including diagnostic labs and testing facilities, it has helped to fuel the growth of the India kidney function test market.

Key Market Drivers

Increasing Prevalence of Chronic Kidney Disease

Chronic kidney disease (CKD) is a major public health concern in India, and the prevalence of the disease has been increasing in recent years. Around 10% of the Indian population suffers from chronic kidney disease, and every year over 1 lakh cases of renal failure. There are several factors that have contributed to the rising incidence of CKD in India, including Diabetes which is one of the leading causes of chronic kidney disease in India.

According to the International Diabetes Federation, India has the second-largest population of people with diabetes in the world, with an estimated 77 million people affected. Hypertension or high blood pressure is another major contributor to the development of chronic kidney disease in India. Hypertension is common in India, with an estimated 25-30% of the adult population affected. Unhealthy lifestyle choices, such as a diet high in salt and fat, lack of physical activity, and tobacco use, are also contributing to the increasing prevalence of chronic kidney disease in India. India has a high proportion of aged population, and older adults are more likely to develop chronic kidney disease than younger individuals. Environmental factors such as exposure to environmental toxins and pollution can also contribute to the development of chronic kidney disease. The increasing prevalence of chronic kidney disease in India has significant implications for public health, as the disease can lead to serious complications such as kidney failure, cardiovascular disease, and premature death. Early detection and management of this disease are critical in reducing the burden of the disease in India, and kidney function tests play an important role in achieving this goal. These factors are anticipated to grow the India kidney function test market.

Growing Awareness regarding Kidney Diseases

There has been a growing awareness about kidney disease in India in recent years. Several factors have contributed to this awareness, including Increasing prevalence of kidney disease in India has led to increased attention and awareness about the disease among the public. The Indian government has launched several initiatives aimed at raising awareness about kidney disease, such as the National Program for Prevention and the National Health Mission. The Indian media has played a significant role in raising awareness about kidney disease through articles, television shows, and other forms of media. Patient advocacy groups, several patient advocacy groups in India are working to raise awareness about kidney disease and the importance of early detection and management. Healthcare professionals, including doctors and nurses, are also playing a critical role in raising awareness about kidney disease and encouraging patients to undergo kidney function tests for early detection of kidney disease.

The growing awareness about kidney disease in India is helping to improve early detection and management of the disease. This is important in reducing the burden of kidney disease in India, which has significant implications for public health and the economy. These factors are anticipated to grow the India kidney function test market.

Key Market Challenges

Limited Access to Healthcare in Rural Areas

One of the primary challenges in the India kidney function test market is the limited access to healthcare, especially in rural and remote areas. Many regions in India lack adequate healthcare infrastructure, making it difficult for individuals to undergo routine kidney function tests like serum creatinine, blood urea nitrogen (BUN), and glomerular filtration rate (GFR). In rural areas, there is often a shortage of diagnostic centers equipped with advanced testing equipment and skilled healthcare personnel. This limits early detection and monitoring of kidney diseases, which are prevalent in India due to factors such as diabetes, hypertension, and high rates of chronic kidney disease (CKD). Overcoming this challenge requires significant investments in infrastructure, awareness campaigns, and mobile diagnostic solutions to ensure better access to kidney function tests for underserved populations.

High Cost of Advanced Diagnostic Technologies

The high cost of advanced kidney function testing technologies is another major challenge in the market. Tests like GFR and molecular-based diagnostics can be expensive, particularly in the private healthcare sector, which limits accessibility for lower-income populations. Additionally, the need for specialized equipment and skilled technicians further increases the cost of these tests. This financial barrier often prevents timely detection and effective management of kidney diseases. While basic tests such as serum creatinine and BUN are more affordable, they may not provide a comprehensive understanding of kidney health. Making advanced kidney function tests more affordable and accessible is crucial to improving the overall management of kidney diseases in India.

Key Market Trends

Increasing Adoption of Point-of-Care (POC) Testing

A growing trend in India's kidney function test market is the increasing adoption of Point-of-Care (POC) testing. POC testing allows for quick and accurate results at the patient's location, eliminating the need for laboratory visits. This is especially beneficial in rural and remote areas, where access to diagnostic centers is limited. Devices like portable creatinine analyzers and handheld diagnostic kits are gaining popularity, enabling healthcare professionals to monitor kidney function in real-time. These tests provide immediate results, making them invaluable for managing chronic kidney disease (CKD) and acute kidney injury (AKI). The ease of use and affordability of POC tests are driving their uptake in both primary healthcare settings and mobile health units, ensuring that kidney function testing becomes more accessible to a broader segment of the population. As healthcare providers continue to invest in these technologies, the adoption of POC testing is expected to grow, particularly for high-risk individuals in rural regions.

Shift Toward Integrated and Comprehensive Kidney Health Monitoring Solutions

Another emerging trend is the shift toward integrated and comprehensive kidney health monitoring solutions. Traditional kidney function tests, such as serum creatinine and BUN, are increasingly being complemented by more advanced diagnostic tools, including urine albumin-to-creatinine ratio (ACR) tests and genetic screening. Integrated platforms that combine various diagnostic tests, patient data, and real-time monitoring are gaining traction, offering a more holistic approach to kidney health management. The integration of technologies like artificial intelligence (AI) and machine learning into kidney function testing is also on the rise. These innovations can help healthcare providers identify early-stage kidney damage, predict disease progression, and personalize treatment plans for patients. With CKD becoming a significant public health concern in India, the demand for comprehensive and integrated solutions for monitoring kidney health is expected to grow, driving market development and improving outcomes for patients.

Segmental Insights

Component Insights

Based on component, the dipsticks category is currently dominating the India Kidney Function Test market due to their affordability, ease of use, and efficiency in providing rapid results. Dipsticks, also known as urine test strips, are widely used for initial screening and monitoring of kidney function. They are designed to detect a range of parameters such as protein, glucose, pH, specific gravity, and the presence of other substances like blood or ketones in urine, which are indicative of kidney health.

One of the key factors driving the dominance of dipsticks in the market is their low cost, making them accessible for widespread use, especially in resource-constrained settings and rural areas. These test strips provide quick results, making them ideal for point-of-care (POC) testing, where immediate feedback is needed for timely diagnosis and treatment. Dipsticks are commonly used in outpatient clinics, diagnostic centers, and even at home for routine monitoring of kidney function, particularly in individuals with risk factors such as diabetes, hypertension, or a family history of kidney disease.

Moreover, the simplicity of using dipsticks, requiring minimal training for healthcare providers and patients, contributes to their popularity. This ease of use is vital in improving early detection and continuous monitoring of kidney conditions, helping reduce the burden of chronic kidney disease (CKD) and acute kidney injury (AKI) in India. As healthcare accessibility improves and awareness about kidney health grows, the dipstick category is expected to maintain its dominance in the kidney function test market, especially for routine and preliminary screening purposes.

Regional Insights

Based on the region, East India was dominating in India Kidney Function Test Market in 2024, driven by the increasing prevalence of kidney diseases, particularly chronic kidney disease (CKD), and the growing demand for diagnostic services. States like West Bengal, Odisha, Bihar, Jharkhand, and Assam have seen rising rates of conditions such as diabetes and hypertension, which are major risk factors for kidney disease. The high incidence of these diseases in the region has significantly contributed to the demand for kidney function tests like serum creatinine, blood urea nitrogen (BUN), and urine tests.

The region's dominance can also be attributed to several healthcare developments. East India is witnessing improvements in healthcare infrastructure, with diagnostic centers, hospitals, and clinics expanding to meet the growing need for kidney function testing. The adoption of cost-effective and accessible diagnostic tools, such as dipsticks for initial screening and point-of-care (POC) devices, is further driving the growth in the region. Additionally, mobile health units and government-led initiatives aimed at improving healthcare access are ensuring that even underserved areas can benefit from these diagnostic services.

Key Market Players

• Abbott India Ltd
• Roche Diagnostics India Pvt. Ltd
• Siemens Healthineers India
• Bio-Rad Laboratories (India) Pvt. Ltd
• Inbios India
• Swemed Bio Medicals Private Limited
• Merck KGaA
• Danaher Corporation

Report Scope:

In this report, the India Kidney Function Test Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

India Kidney Function Test Market, By Test Type:

• Urine Test
• Urine Protein Tests
• Creatinine Clearance Tests
• Microalbumin Tests
• Blood Test
• Serum Creatinine Tests
• Glomerular Filtration Rate Tests
• Blood Urea Nitrogen Tests

India Kidney Function Test Market, By Component:

• Dipsticks
• Reagents
• Kits & Essays

India Kidney Function Test Market, By End User:

• Hospitals and Clinics
• Diagnostics Laboratories
• Academic and Research Institute

India Kidney Function Test Market, By Region:

• North India
• South India
• East India
• West India

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the India Kidney Function Test Market.

Available Customizations:

India Kidney Function Test Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).